Tag Archives: Emerging Markets

BRIC Nations' "Blossoming Healthcare Budgets" Revive Clinical Trials Opportunities

While some clinical trial sponsors have been driven out of the BRIC nations, a rise in rank for each country — Brazil, Russia, India, China — is expected over the next four years, indicating “blossoming healthcare budgets and markets that are ripe with opportunities for development”. According to a Thomson Reuters report, Overcoming Clinical Challenges in BRIC […]
Posted in Emerging Markets, Europe, Global, R&D | Also tagged , , | Leave a comment

What MNCs Can Learn from Generics Companies

In the last three decades, MNCs have contributed greatly to the transfer of knowledge to generic companies in areas such as technology, marketing know-how, working methods, management techniques, R&D, and branding. However, now is the time that MNCs can also learn significantly from generic companies amid the changing global industry landscape. This evolution has enabled […]
Posted in Emerging Markets, Guest Blog, Strategy | Also tagged , , , | Leave a comment

Digital Education a Key Bridge to Tapping Emerging Markets

In our second Q&A installment previewing next month’s iPharma2014 conference in New York City, we spoke with David Stern, executive VP of global commercial operations with OvaScience. Stern will be presenting on “Going Global – Innovative Tactics to Engage Emerging Markets and Extend the Global Strategy to a Regional Level.” Drawing from his time as […]
Posted in Emerging Markets, Global, healthcare, Medical Education, Patient Communication, Strategy | Also tagged , , , | Leave a comment

Bioscience Research: China to Overtake U.S. by 2020

Bioscience research in China is set to overtake the United States within the next five to ten years, according to data from search engine CiteAb.
Posted in Biotech, Emerging Markets, Gene therapy, Global, R&D | Also tagged , , , | Leave a comment

Biopharma's High Performers 2014

Accenture has launched the latest version of its annual study of the biopharmaceutical industry. The High Performance Business (HPB) report analyses  the long-term performance of the 16 largest pharma companies globally, highlighting industry trends, pharmaceutical business performance analysis, and potential implications for the industry.
Posted in Biotech, Global, Strategy | Also tagged , , , , | Leave a comment
  • Categories

  • Meta